Michael Asbach,

DMSc, PA-C, Psych-CAQ

Michael Asbach

DMSc, PA-C, Psych-CAQ

Associate Director, Interventional Psychiatry, DENT Neurologic Institute

Michael Asbach,

DMSc, PA-C, Psych-CAQ

Associate Director, Interventional Psychiatry, DENT Neurologic Institute

Michael Asbach is the Associate Director of Interventional Psychiatry at DENT Neurologic Institute. He is a clinical professor of psychiatry at Daemen College, D’Youville University, and Rochester Institute of Technology. Dr. Asbach received his master’s in physician assistant studies from Daemen College. His Doctorate of Medical Science degree is with a concentration in healthcare leadership. Dr. Asbach is a member of the American Academy of Physician Assistants and the Association of Physician Assistants in Psychiatry, and he serves as the Chair of Industry Relations for the New York State Society of Physician Assistants. Dr. Asbach is a nationally recognized educator who has provided over 400 lectures on behalf of the pharmaceutical industry and medical education companies.

Michael's Shared Resources

Study Compares Efficacy of Once-Daily and Twice-Daily Deutetrabenazine

Researchers of this study evaluated the bioequivalence of once-daily and twice-daily formulations of deutetrabenazine in a randomized crossover trial involving...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Study Reveals Profound Impact of Tardive Dyskinesia on Caregivers in the United States

Researchers of a survey-based study in the United States involving 162 caregivers, highlight the profound impact of tardive dyskinesia (TD)...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Tardive Dyskinesia Impact Scale Enhances Patient-Centric Assessment of the Movement Disorder

In a recent study, researchers aimed to develop and evaluate the Tardive Dyskinesia Impact Scale (TDIS), a patient-reported outcome measure...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Clinician’s Tardive Inventory Emerges as a Reliable Tool for Assessing Tardive Dyskinesia Symptoms and Impact

Researchers of a recent study focused on developing and validating the Clinician's Tardive Inventory (CTI) to address the limitations of...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Expert Panel Sets New Guidelines for Assessing Tardive Dyskinesia’s Impact on Patients’ Lives

An expert advisory panel has developed consensus recommendations for assessing the impact of tardive dyskinesia (TD) on patient functioning in...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Prolonged Use of Benztropine in Movement Disorders Raises Concern: Discrepancy Between Psychiatry and Primary Care Prescriptions

In a recent study, researchers performed a retrospective analysis of healthcare claims to investigate the real-world treatment patterns of benztropine...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Share